clear1-day
CLEARLAB SG PTE. LTD. · Model clear1-day · UDI-DI 08887861972606
Description
The clear1-day (hioxifilcon A) Daily Disposable Soft Contact Lens is available as a single vision spherical lens. The hydrophilic nature of this material allows the lens to become soft and pliable when immersed in an aqueous solution. The non-ionic lens material, (hioxifilcon A) is a ultra high molecular weight random copolymer of 2- hydroxyethyl methacrylate (2-HEMA) and 2,3-Dihydroxpropyl Methacrylate (Glycerol Methacrylate, GMA) cross-linked with ethylene glycol dimethacrylate. It consists of 42% hioxifilcon A and 58% water by weight when immersed in a buffered saline solution. The lens is available with a pale blue visibility- handling tint, color additive 'Reactive Blue # 4', 21 CFR part 73.3121. The United States Adopted Names Council (USAN) has adopted the (hioxifilcon A) name. In the hydrated state, the lens conforms to the curvature of the eye covering the cornea and extending slightly beyond the limbus forming a colorless, transparent optical surface. The hydrophilic properties of the lens require that it be maintained in a fully hydrated state in a solution compatible with the eye. If the lens dries out, it will become hard and appear somewhat warped however, it will return to its proper configuration when completely rehydrated in the proper storage solution.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-09-30 | Alcon Research LLC | Potential for a weak seal in some units resulting in compromise in sterility. |
| 2025-06-12 | Johnson & Johnson Vision Care, Inc. | Due to defects (bubbles/voids) identified during standard finished goods testing |
| 2024-08-08 | Alcon Research LLC | Material with a quality issue was used in contact lens production, so contact lenses may not meet quality and/or performance standards for the entirety of their labeled shelf life, |
| 2023-02-14 | CooperVision, Inc. | The lenses manufactured in the affected lot were made with a misaligned axis resulting in lenses with the incorrect power. |
| 2022-12-27 | CooperVision, Inc. | Lenses may be of the incorrect power. A patient who uses an affected lens may experience poor visual acuity. |
| 2021-05-19 | CooperVision Inc. | Misaligned placement of an axis mark can cause the patient to experience blurred vision |
| 2021-05-19 | CooperVision Inc. | Misaligned placement of an axis mark can cause the patient to experience blurred vision |
| 2021-05-19 | CooperVision Inc. | Misaligned placement of an axis mark can cause the patient to experience blurred vision |
| 2021-05-19 | CooperVision Inc. | Misaligned placement of an axis mark can cause the patient to experience blurred vision |
| 2021-05-19 | CooperVision Inc. | Misaligned placement of an axis mark can cause the patient to experience blurred vision |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docs